Visine eye drops

Visine is a well-known brand of eye drops designed to alleviate redness and irritation. The brand was originally developed and commercialized by Pfizer, a major American pharmaceutical corporation. It gained worldwide recognition for its active ingredients aimed at relieving minor eye congestion and symptoms associated with allergens or environmental irritants.

Over the decades, the ownership of Visine has transitioned through major corporate restructuring. Following the spinoff of Pfizer's consumer healthcare division and its subsequent merger with GlaxoSmithKline's consumer unit, the brand eventually became part of Kenvue. Kenvue emerged as an independent company after separating from Johnson & Johnson in 2023, taking over a vast portfolio of household health brands.

Today, Visine is manufactured in several global locations to meet international demand, with significant production facilities located in Belgium. As the brand remains a leader in the over-the-counter eye care market, its operations continue to focus on clinical efficacy and broad accessibility under the management of Kenvue, which is headquartered in the United States.